GAOMA Therapeutics is grateful to UCB Pharma for its invitation to the event “ELLIPSE: the epilepsy in three dimensions” organized by the pharma company on September 11th and 12th, 2020.
GAOMA will participate in a panel discussion dedicated to innovations in epilepsy care, to present its approach in treating epilepsy, notably through the case of its drug candidate GAO-3-02.